Stay updated on Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    3 days ago
    No Change Detected
  3. Check
    4 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' on the webpage has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change likely pertains to medical and healthcare-related publications and documentation.
    Difference
    43%
    Check dated 2024-05-22T07:42:54.000Z thumbnail image
  4. Check
    5 days ago
    No Change Detected
  5. Check
    6 days ago
    No Change Detected
  6. Check
    15 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the Estimated Study Completion Date, which is now estimated to be in 2025 instead of the previous estimate. This change may indicate a shift in the timeline for the study related to Sacituzumab Govitecan in patients with metastatic castration-resistant prostate cancer.
    Difference
    0.0%
    Check dated 2024-05-11T17:10:54.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The webpage has been updated to show that the study status has changed from Terminated Recruiting to Active, not recruiting. This change indicates that the study is now actively ongoing and accepting participants.
    Difference
    4%
    Check dated 2024-05-10T08:17:48.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:40:41.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.